In summary, our study provided evidence that resveratrol could inhibit EMT in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression, and this might the potential mechanism of resveratrol on inhibition of invasion and metastases (Figure 7). Here, CDH1 is linked to colorectal cancer.